Related Experiment Video
Updated: Feb 8, 2026

An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
Published on: September 13, 2016
Nanotechnology in retinal drug delivery
Sibo Jiang1, Yesenia L Franco1, Yan Zhou2
1Department of Pharmaceutics, University of Florida, Orlando, FL 32827, USA.
Nanotechnology offers promising solutions for retinal drug delivery, improving targeted and sustained treatment for conditions like age-related macular degeneration and diabetic retinopathy, addressing a key unmet need in ophthalmology.
Area of Science:
- Ophthalmology
- Nanotechnology
- Drug Delivery Systems
Background:
- Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) are primary causes of blindness in older adults.
- Current treatments aim to prevent vision loss, but efficient drug delivery to the posterior eye segment remains a challenge.
- Intravitreal injections are common but invasive, posing risks with repeated administration.
Purpose of the Study:
- To review the application of nanotechnology in delivering therapeutic agents to the retina.
- To explore advancements in retinal drug delivery systems from 2007 to 2017.
- To highlight nanotechnology's potential to overcome limitations of current ocular drug delivery methods.
Main Methods:
- Literature review of studies published between 2007 and 2017 via PubMed.
- Identification of research evaluating nanotechnology for posterior eye segment drug delivery.
- Analysis of various ocular drug delivery routes and nanosystems.
Main Results:
- Nanotechnology provides targeted and sustained delivery of therapeutic agents to the retina.
- Various nanosystems (hydrogels, liposomes, dendrimers, micelles) have been investigated.
- These systems are utilized across different delivery routes (intravitreal, periocular, subretinal, systemic).
Conclusions:
- Nanotechnology holds significant potential to revolutionize retinal drug delivery.
- It offers improved therapeutic efficacy and patient compliance for treating retinal diseases.
- Further research into nanosystems can address unmet needs in ophthalmic drug delivery.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Pharmacokinetics: Drug–Drug Interactions
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...

